Roberts Johanna, an insider at Penumbra Inc (PEN), sold 64,736 shares of the company on November 24, 2025, at a price of $300.06 per share, resulting in a total transaction value of $19.42 million. Following this sale, Johanna retains 64,736 shares of the company.
Penumbra Inc, headquartered in Alameda, California, specializes in innovative medical products, particularly in thrombectomy. The firm focuses on developing solutions for conditions such as Pulmonary Embolism, Deep Vein Thrombosis, and Ischemic Stroke, among others. With a market capitalization of $11.6 billion, Penumbra has a P/E ratio of 70.66 and an EPS of 4.14. The company is set to report its upcoming earnings on April 21, 2026, with an estimated EPS of $1.10 and revenue of $373.7 million.
Insider transactions provide transparency into the actions of company executives and board members. However, such sales may occur for various reasons, including diversification and personal financial needs. Investors should consider these transactions as part of a broader analysis, examining patterns across multiple insiders and time periods rather than isolated events.